Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Sandoz inaugurated two separate facilities in Austria and Germany dedicated to the production of penicillin and the development of biosimilars, respectively. The generic drugmaker invested €150…
Click here to view original post
